Company to take part in Fireside Chat Thursday, February 18th, 2021 at 12:30 pm PT / 3:30 pm ET SUNNYVALE, Calif. , Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health , Life Science and Diagnostic Tools
SUNNYVALE, Calif. , Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott , M.D., MBA to the company's Board of Directors, effective as of February 12, 2021 . Dr. Scott brings significant experience as a physician executive with
Company to take part in Fireside Chat Tuesday, March 2nd, 2021 at 11:50 am PT / 2:50 pm ET SUNNYVALE, Calif. , Feb. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the Cowen Annual Health Care Conference .
SUNNYVALE, Calif. , April 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2021, ended March 31, 2021, after the market close on Tuesday April 27, 2021. Management will host a conference call to review the results
Exceptional, Fan-beam Imaging for the Radixact® System Increases Radiation Treatment Options SUNNYVALE, Calif. , April 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the innovative ClearRT ™ helical fan-beam kVCT imaging* capability has now been in clinical use
SUNNYVALE, Calif. , April 26, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY ) announced today the appointment of Jean-Philippe Pignol , M.D., Ph.D. as its chief medical & technology officer, effective as of April 15, 2021 . In this new role, Dr.
SUNNYVALE, Calif. , April 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2021 ended March 31, 2021 . Third Quarter Fiscal 2021 Summary Net revenue of $102.6 million including $24.9 million of system revenue in
- American Association of Physicists in Medicine (AAPM) Grand Challenge MATCH event was designed to evaluate the potential to track lung tumor motion without fiducial markers in real-time during radiation therapy - Results demonstrate exceptional accuracy is achievable with the Accuray-only
WILKES-BARRE, Pa. and SUNNYVALE, Calif. , May 3, 2021 /PRNewswire/ -- Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated's (NASDAQ: ARAY) newest Synchrony ® technology on both the CyberKnife ® S7™ and
SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Jean-Philippe Pignol , M.D., Ph.D., the company's new Chief Medical & Technology Officer. As a material inducement to Dr.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
